{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:44:56Z","timestamp":1790646296221,"version":"4.1.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.2215\/cjn.09470913","type":"journal-article","created":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T03:23:04Z","timestamp":1403234584000},"page":"1254-1262","source":"Crossref","is-referenced-by-count":113,"title":["Bone Mineral Density and Serum Biochemical Predictors of Bone Loss in Patients with CKD on Dialysis"],"prefix":"10.2215","volume":"9","author":[{"given":"Hartmut H.","family":"Malluche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Cantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Monier-Faugere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20230601","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5414\/CNP65235","article-title":"Renal osteodystrophy: What\u2019s in a name? Presentation of a clinically useful new model to interpret bone histologic findings.","volume":"65","author":"Malluche","year":"2006","journal-title":"Clin Nephrol"},{"key":"R2-17-20230601","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"R5-17-20230601","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","article-title":"Bone mineral density and fracture risk in older individuals with CKD.","volume":"7","author":"Yenchek","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R6-17-20230601","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease.","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int"},{"key":"R7-17-20230601","first-page":"1","article-title":"Bone densitometry: Patients with end-stage renal disease.","volume":"8","author":"Erlichman","year":"1996","journal-title":"Health Technol Assess (Rockv"},{"key":"R8-17-20230601","first-page":"246","article-title":"Values of noninvasive techniques in predicting bone histology.","volume":"77","author":"Malluche","year":"1988","journal-title":"Ann Chir Gynaecol"},{"key":"R9-17-20230601","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00198-003-1462-8","article-title":"Bone mineral density and prevalent vertebral fractures in men and women.","volume":"15","author":"Cauley","year":"2004","journal-title":"Osteoporos Int"},{"key":"R10-17-20230601","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1172\/JCI113523","article-title":"Age and bone mass as predictors of fracture in a prospective study.","volume":"81","author":"Hui","year":"1988","journal-title":"J Clin Invest"},{"key":"R11-17-20230601","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/JCD:7:1:1","article-title":"Official positions of the International Society for Clinical Densitometry.","volume":"7","author":"Leib","year":"2004","journal-title":"J Clin Densitom"},{"key":"R12-17-20230601","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patients.","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R13-17-20230601","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0009-9120(90)80019-F","article-title":"Alkaline phosphatase isozymes: Recent progress.","volume":"23","author":"Fishman","year":"1990","journal-title":"Clin Biochem"},{"key":"R14-17-20230601","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.bone.2006.11.027","article-title":"PINP: A serum biomarker of bone formation in the rat.","volume":"40","author":"Hale","year":"2007","journal-title":"Bone"},{"key":"R15-17-20230601","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1359\/jbmr.2000.15.7.1337","article-title":"Tartrate-resistant acid phosphatase 5b: A novel serum marker of bone resorption.","volume":"15","author":"Halleen","year":"2000","journal-title":"J Bone Miner Res"},{"key":"R16-17-20230601","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1074\/jbc.M807994200","article-title":"Characterization of the structural features and interactions of sclerostin: Molecular insight into a key regulator of Wnt-mediated bone formation.","volume":"284","author":"Veverka","year":"2009","journal-title":"J Biol Chem"},{"key":"R17-17-20230601","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J"},{"key":"R18-17-20230601","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/jbmr.173","article-title":"Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody.","volume":"26","author":"Padhi","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R19-17-20230601","doi-asserted-by":"crossref","first-page":"24113","DOI":"10.1074\/jbc.M301716200","article-title":"Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity.","volume":"278","author":"Kusu","year":"2003","journal-title":"J Biol Chem"},{"key":"R20-17-20230601","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood-2008-03-145169","article-title":"The role of Dickkopf-1 in bone development, homeostasis, and disease.","volume":"113","author":"Pinzone","year":"2009","journal-title":"Blood"},{"key":"R21-17-20230601","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1182\/blood-2008-11-191577","article-title":"Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma.","volume":"114","author":"Fulciniti","year":"2009","journal-title":"Blood"},{"key":"R22-17-20230601","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1359\/jbmr.060311","article-title":"Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.","volume":"21","author":"Morvan","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R23-17-20230601","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"key":"R24-17-20230601","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/joe.1.07059","article-title":"Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity.","volume":"192","author":"Liu","year":"2007","journal-title":"J Endocrinol"},{"key":"R25-17-20230601","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice.","volume":"291","author":"Liu","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R26-17-20230601","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0009-8981(83)90404-7","article-title":"Relationship of plasma tartrate resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism.","volume":"133","author":"St\u0115pan","year":"1983","journal-title":"Clin Chim Acta"},{"key":"R27-17-20230601","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/8756-3282(87)90002-0","article-title":"Bone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women.","volume":"8","author":"St\u0115p\u00e1n","year":"1987","journal-title":"Bone"},{"key":"R28-17-20230601","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF02556662","article-title":"Serum tartrate-resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis.","volume":"45","author":"de la Piedra","year":"1989","journal-title":"Calcif Tissue Int"},{"key":"R29-17-20230601","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1359\/jbmr.081225","article-title":"Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate.","volume":"24","author":"Cheung","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R31-17-20230601","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.2010121275","article-title":"Discriminants of prevalent fractures in chronic kidney disease.","volume":"22","author":"Nickolas","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R32-17-20230601","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/en.2007-0270","article-title":"Targeting the Wnt\/beta-catenin pathway to regulate bone formation in the adult skeleton.","volume":"148","author":"Baron","year":"2007","journal-title":"Endocrinology"},{"key":"R33-17-20230601","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST).","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"key":"R34-17-20230601","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease.","volume":"39","author":"Balemans","year":"2002","journal-title":"J Med Genet"},{"key":"R35-17-20230601","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R36-17-20230601","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.","volume":"24","author":"Li","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R37-17-20230601","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jbmr.14","article-title":"Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength.","volume":"25","author":"Ominsky","year":"2010","journal-title":"J Bone Miner Res"},{"key":"R38-17-20230601","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy.","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R39-17-20230601","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD.","volume":"8","author":"Pelletier","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R40-17-20230601","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2011-2152","article-title":"Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.","volume":"97","author":"Amrein","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R41-17-20230601","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/jbmr.479","article-title":"Determinants of serum sclerostin in healthy pre- and postmenopausal women.","volume":"26","author":"Ardawi","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R42-17-20230601","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ndt\/gfr270","article-title":"Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.","volume":"27","author":"Cejka","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R43-17-20230601","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1210\/jc.2013-2113","article-title":"Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women.","volume":"98","author":"Durosier","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R44-17-20230601","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.","volume":"26","author":"M\u00f6dder","year":"2011","journal-title":"J Bone Miner Res"},{"key":"R45-17-20230601","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00198-010-1525-6","article-title":"Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women\u2014the six-month effect of risedronate and teriparatide.","volume":"23","author":"Polyzos","year":"2012","journal-title":"Osteoporos Int"},{"key":"R46-17-20230601","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease.","volume":"28","author":"Nickolas","year":"2013","journal-title":"J Bone Miner Res"},{"key":"R47-17-20230601","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1007\/s00198-011-1838-0","article-title":"FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages.","volume":"23","author":"Desjardins","year":"2012","journal-title":"Osteoporos Int"},{"key":"R48-17-20230601","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/ndt\/gfg403","article-title":"Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.","volume":"18","author":"Ure\u00f1a","year":"2003","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201407000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:44:30Z","timestamp":1786369470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201407000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.09470913","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}